Insulin solutions must be placed in an infusion pump and piggybacked into the lower distal port of a maintenance i.v. line with a rate of at least 20 mL/hr. (Use 0.9% sodium chloride injection if ...
Medical Device Network on MSN1d
Nearly a third of FDA medical device adverse event reports filed lateA new study found that 9.1% of medical device AEs were reported to the FDA 180 days later than required over a three-year ...
Insulin infusion sets without pumps were also tested under a separate pressure protocol to simulate rapid decompression. This ...
"The risk of diabetic ketoacidosis linked to continuous subcutaneous insulin infusion in type 1 diabetes has significantly ...
The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to ...
An insulin pump can more closely mimic the way a healthy pancreas works, through a Continuous Subcutaneous Insulin Infusion (CSII), replaces the need for frequent injections by delivering precise ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps.
For instance, chemotherapy for cancer patients requires precise and controlled drug delivery, which infusion pumps facilitate. Similarly, patients with diabetes often need insulin infusion pumps ...
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system ... traditional insulin pumps, pump supplies, and pharmaceuticals.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback